Clinical trial
Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective…
NCT00247312 · Schiffler Cancer Center, Other · Completed
Key facts
| NCT number | NCT00247312 |
|---|---|
| Title | Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial |
| Official title | Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial |
| Lead sponsor | Schiffler Cancer Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasm |
| Intervention type | Radiation |
| Interventions | Pd-103 |
| Enrollment | 319 |
| Start date | Oct 1, 2005 |
| Primary completion | Nov 1, 2015 |
| Completion | Nov 1, 2015 |
| First posted | Nov 1, 2005 |
| Last update posted | Nov 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: